The Madras High Court has recently allowed an appeal by Ab Initio Technology LLC, a US-based company, against the Patent ...
The Indian Patent Office's decision to cancel the patent for Novartis's major heart drug, Vymada, has added a new chapter to ...
KFF Health News on MSN
FDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office
Drug industry officials and analysts praised the FDA’s plans to streamline regulation of “biosimilars,” which are cheaper alternatives to biologic drugs. But patents that block such drugs from the U.S ...
Swiss newspapers have questioned the deal struck with Washington and concessions made by Switzerland to allow the tariff rate ...
FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.
AEW could be moving closer to launching its own streaming service, with its current product streaming on HBO Max in the ...
The U.S. Court of Appeals for the Federal Circuit on Friday affirmed a district court’s award of attorney’s fees to an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results